Researchers at the Experimental and Clinical Research Center (ECRC), a joint institution of the Max Delbrück Center and ...
Researchers at the Experimental and Clinical Research Center in Berlin are developing a targeted treatment for muscular ...
An estimated 1 in 8,000 individuals, or 870,000 people worldwide, are affected by Facioscapulohumeral muscular dystrophy ...
Solid Biosciences advances gene therapies for muscular and cardiac diseases, gaining FDA clearance for SGT-212 and targeting ...
Shaun Rowlands' son suffers from Duchenne muscular dystrophy which means his home is fitted with electronic equipment like ...
Dublin Live on MSN3d
Dublin mum heaps praise on son's 'amazing' friends after rare muscle condition diagnosis as fundraising continuesSeven-year-old Archie Ennis has been diagnosed with Duchenne muscular dystrophy, a genetic condition that causes muscle ...
UHealth and Holtz Children’s Hospital physicians are exploring a new gene therapy called ELEVIDYS to treat older Duchenne muscular dystrophy (DMD) patients. The therapy delivers a functional ...
UC Davis Health has premiered a new documentary on a family’s urgent journey across the globe to get their toddler in a clinical trial for patients with Duchenne Muscular Dystrophy, or DMD.
Insmed (INSM) reported preliminary 2024 revenue results for its drug Arikayce and issued 2025 revenue guidance. Read more ...
The upside in Sarepta's share price can be attributed to the encouraging sales performance of its DMD gene therapy, which has demonstrated blockbuster potential.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback